Apoptosis signal-regulating kinase 1 attenuates atrial natriuretic peptide secretion

Biochemistry

Volumn 47, Issue 38, 2008, Pages 10041-10048

  Shan, Xiaoyin ^a   Wang, Hongmei ^a   Margulies, Kenneth B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 608 BRB II/III Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; PAINTING;

APOPTOSIS SIGNAL-REGULATING KINASE 1; ATRIAL NATRIURETIC PEPTIDE; CARDIAC HYPERTROPHY; CDNA LIBRARIES; CELLULAR MECHANISMS; CO LOCALIZATIONS; COEXPRESSED; CULTURE MEDIUM; ENDOGENOUS PEPTIDE; HEART FAILURE; HELA CELLS; HUMAN HEART; IN-VITRO; INDIRECT IMMUNOFLUORESCENCE MICROSCOPY; KINASE ACTIVITIES; NATRIURETIC; STAINING PATTERNS; WILD-TYPE; YEAST TWO-HYBRID;

AMINES;

APOPTOSIS SIGNAL REGULATING KINASE 1; ATRIAL NATRIURETIC FACTOR; PROTEIN PRECURSOR;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA LIBRARY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; HEART FAILURE; HEART HYPERTROPHY; HELA CELL; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TWO HYBRID SYSTEM; WILD TYPE;

ATRIAL NATRIURETIC FACTOR; DOWN-REGULATION; HELA CELLS; HUMANS; MAP KINASE KINASE KINASE 5; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 52249122191     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi800972z     Document Type: Article

References (41)

1. McGrath, M. F., de Bold, M. L., and de Bold, A. J. (2005) The endocrine function of the heart. Trends Endocrinol. Metab. 16, 469-477.
2. Cataliotti, A., and Burnett, J. C., Jr. (2005) Natriuretic peptides: Novel therapeutic targets in heart failure. J. Invest. Med. 53, 378-384.
3. Fukai, D., Wada, A., Tsutamoto, T., and Kinoshita, M. (1998) Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure. Jpn. Circ. J. 62, 604-610.
4. Yamamoto, K., Burnett, J. C., Jr., and Redfield, M. M. (1997) Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am. J. Physiol. 273, H2406-H2414.
5. Ito, T., Yoshimura, M., Nakamura, S., Nakayama, M., Shimasaki, Y., Harada, E., Mizuno, Y., Yamamuro, M., Harada, M., Saito, Y., Nakao, K., Kurihara, H., Yasue, H., and Ogawa, H. (2003) Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 107, 807-810.
6. Lewicki, J. A., Greenberg, B., Yamanaka, M., Vlasuk, G., Brewer, M., Gardner, D., Baxter, J., Johnson, L. K., and Fiddes, J. C. (1986) Cloning, sequence analysis, and processing of the rat and human atrial natriuretic peptide precursors. Fed. Proc. 45, 2086-2090.
7. Rosenkranz, A. C., Woods, R. L., Dusting, G. J., and Ritchie, R. H. (2003) Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: Importance of cyclic GMP. Cardiovasc. Res. 57, 515-522.
8. Kishimoto, I., Rossi, K., and Garbers, D. L. (2001) A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 98, 2703-2706.
9. Yan, W., Wu, F., Morser, J., and Wu, Q. (2000) Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc. Natl. Acad. Sci. U.S.A. 97, 8525-8529.
10. Wolf, K., Kurtz, A., Pfeifer, M., Hocherl, K., Riegger, G. A., and Kramer, B. K. (2001) Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pfluegers Arch. 442, 212-217.
11. Ruskoaho, H., Kinnunen, P., Taskinen, T., Vuolteenaho, O., Leppaluoto, J., and Takala, T. E. (1989) Regulation of ventricular atrial natriuretic peptide release in hypertrophied rat myocardium. Effects of exercise. Circulation 80, 390-400.
12. Wang, X. S., Diener, K., Jannuzzi, D., Trollinger, D., Tan, T. H., Lichenstein, H., Zukowski, M., and Yao, Z. (1996) Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase. J. Biol. Chem. 271, 31607-31611.
13. Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90-94.
14. Matsukawa, J., Matsuzawa, A., Takeda, K., and Ichijo, H. (2004) The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 136, 261-265.
15. Matsuzawa, A., and Ichijo, H. (2008) Redox control of cell fate by MAP kinase: Physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochim. Biophys. Acta XXX-XXX.
16. Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., and Ichijo, H. (2001) ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2, 222-228.
17. Yamaguchi, O., Higuchi, Y., Hirotani, S., Kashiwase, K., Nakayama, H., Hikoso, S., Takeda, T., Watanabe, T., Asahi, M., Taniike, M., Matsumura, Y., Tsujimoto, I., Hongo, K., Kusakari, Y., Kurihara, S., Nishida, K., Ichijo, H., Hori, M., and Otsu, K. (2003) Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling. Proc. Natl. Acad. Sci. U.S.A. 100, 15883-15888.
18. Pickering, T. G. (2002) Effects of stress and behavioral interventions in hypertension: The rise and fall of omapatrilat. J. Clin. Hypertens. (Darien, CT, U.S.) 4, 371-373.
19. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Sideman, J., Smith, J., and Strahl, K. (1987) Current Protocol in Molecular Biology, John Wiley and Sons, New York.
20. He, X., Liu, Y., Sharma, V., Dirksen, R. T., Waugh, R., Sheu, S. S., and Min, W. (2003) ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes. Am. J. Pathol. 163, 243-251.
21. Liu, Y., Yin, G., Surapisitchat, J., Berk, B. C., and Min, W. (2001) Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J. Clin. Invest. 107, 917-923.
22. Taniike, M., Yamaguchi, O., Tsujimoto, I., Hikoso, S., Takeda, T., Nakai, A., Omiya, S., Mizote, I., Nakano, Y., Higuchi, Y., Matsumura, Y., Nishida, K., Ichijo, H., Hori, M., and Otsu, K. (2008) Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy. Circulation 117, 545-552.
23. Nishikimi, T., Maeda, N., and Matsuoka, H. (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc. Res. 69, 318-328.
24. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17, 2596-2606.
25. Morita, K., Saitoh, M., Tobiume, K., Matsuura, H., Enomoto, S., Nishitoh, H., and Ichijo, H. (2001) Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20, 6028-6036.
26. Yuan, Z. Q., Feldman, R. I., Sussman, G. E., Coppola, D., Nicosia, S. V., and Cheng, J. Q. (2003) AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: Implication of AKT2 in chemoresistance. J. Biol. Chem. 278, 23432-23440.
27. Liu, Q., Wilkins, B. J., Lee, Y. J., Ichijo, H., and Molkentin, J. D. (2006) Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth. Mol. Cell. Biol. 26, 3785-3797.
28. Takeda, K., Shimozono, R., Noguchi, T., Umeda, T., Morimoto, Y., Naguro, I., Tobiume, K., Saitoh, M., Matsuzawa, A., and Ichijo, H. (2007) Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J. Biol. Chem. 282, 7522-7531.
29. Yasue, H., Obata, K., Okumura, K., Kurose, M., Ogawa, H., Matsuyama, K., Jougasaki, M., Saito, Y., Nakao, K., and Imura, H. (1989) Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J. Clin. Invest. 83, 46-51.
30. Biondi, R. M., and Nebreda, A. R. (2003) Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem. J. 372, 1-13.
31. Giordano, F. J. (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 115, 500-508.
32. Higuchi, Y., Otsu, K., Nishida, K., Hirotani, S., Nakayama, H., Yamaguchi, O., Hikoso, S., Kashiwase, K., Takeda, T., Watanabe, T., Mano, T., Matsumura, Y., Ueno, H., and Hori, M. (2003) The small GTP-binding protein Rac1 induces cardiac myocyte hypertrophy through the activation of apoptosis signal-regulating kinase 1 and nuclear factor-κ B. J. Biol. Chem. 278, 20770-20777.
33. Xiang, G., Seki, T., Schuster, M. D., Witkowski, P., Boyle, A. J., See, F., Martens, T. P., Kocher, A., Sondermeijer, H., Kram, H., and Itescu, S. (2005) Catalytic degradation of vitamin D upregulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J. Biol. Chem. 280, 39394-39402.
34. Kashiwase, K., Higuchi, Y., Hirotani, S., Yamaguchi, O., Hikoso, S., Takeda, T., Watanabe, T., Taniike, M., Nakai, A., Tsujimoto, I., Matsumura, Y., Ueno, H., Nishida, K., Hori, M., and Otsu, K. (2005) CaMKII activates ASK1 and NF-κB to induce cardiomyocyte hypertrophy. Biochem. Biophys. Res. Commun. 327, 136-142.
35. Szegezdi, E., Logue, S. E., Gorman, A. M., and Samali, A. (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 7, 880-885.
36. Trombetta, E. S., and Parodi, A. J. (2003) Quality control and protein folding in the secretory pathway. Annu. Rev. Cell Dev. Biol. 19, 649-676.
37. Bloch, K. D., Jones, S. W., Preibisch, G., Seipke, G., Seidman, C. E., and Seidman, J. G. (1987) Proatrial natriuretic factor is phosphorylated by rat cardiocytes in culture. J. Biol. Chem. 262, 9956-9961.
38. +-ATPase. Role in protein folding and biogenesis. J. Biol. Chem. 273, 21744-21751.
39. Redondo, J., Bishop, J. E., and Wilkins, M. R. (1998) Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br. J. Pharmacol. 124, 1455-1462.
40. Feng, J. A., Perry, G., Mori, T., Hayashi, T., Oparil, S., and Chen, Y. F. (2003) Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice. Clin. Exp. Pharmacol. Physiol. 30, 343-349.
41. Franco, V., Chen, Y. F., Oparil, S., Feng, J. A., Wang, D., Hage, F., and Perry, G. (2004) Atrial natriuretic peptide dose-dependently inhibits pressure overload-induced cardiac remodeling. Hypertension 44, 746-750.